- HWI group
- HWI Campus
- Artificial Intelligence
HWI group – services for active ingredients,
medicinal products and medical devices
The HWI group offers a broad range of individual and specialised pharmaceutical services for the pharma, biotech and medtech sector, particularly for active ingredients, medicinal products and medical devices. Benefit from our long-standing experience in laboratory services, reference standard services, vigilance and quality services, API assessment and drug development as well as regulatory affairs services.
HWI Campus in Ruelzheim
Pharmaceutical companies, service providers and partners of HWI can register at the HWI Campus in Ruelzheim and flexibly make use of all HWI group services. Particularly pharmaceutical companies from non-EU countries.
The HWI Campus also offers innovative services: from a one-stop shop and technology platforms to AI-based service solutions.
KIKS — Artificial Intelligence for Clinical Trials!
As a partner of the KIKS ecosystem, HWI is a winner of the AI Innovation Competition by the Federal Ministry for Economic Affairs and Energy.
KIKS intends to connect and evaluate medical data electronically in the future. The goal is a digital ecosystem from which patients, clinics, pharmaceutical companies and medical device manufacturers can benefit equally
For more information – read here.
One click and a few minutes later, you’ll know who we are and what you can expect from us.
Vigilance & Quality
The active pharmaceutical ingredient (API) is at the heart of our risk-based development. Its properties have a critical influence on the quality of the product. In our ultra-modern clean rooms we can also work with highly potent active ingredients. By using statistical design of experiment (DoE) we offer an efficient pharmaceutical development that completely fulfils the requirements of quality by design.
More than work
Until further notice, the HWI group will take the following measures to ensure that our services are maintained for you.
Click on "Read more" and read the measures in detail.
Today we are shooting with prestigefilm at our site in Frankfurt. Soon you will be able to take a look at the heart of our drug development.
Would you like to know more about how ISO 10993-1:2018 provides a new intelligent approach to biological safety assessment?
Interested? Read more in our latest HWI-blog by Dr. Manuela Schwegler.
Stay up to date:
Reference standards product range
Our reference standard product range covers a wide range of qualified primary and working standards at a cost-effective price–performance ratio.
Take a look at our portfolio! If you can’t find a reference standard, please contact us.
Monday - Friday
08:00 - 17:00 o´clock